Latest News about EYLEA
Recent news which mentions EYLEA
From Benzinga
IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week
October 11, 2020
From Benzinga
Regeneron Snags Upgrade On Reduced Prospects For Rival Eye Disorder Drug
February 25, 2020
From Benzinga
Clearside Biomedical Plunges 60% Following Phase 3 Study Results
November 05, 2018
Tickers
CLSD
From Benzinga
From Benzinga
From Benzinga
From Stocks to Watch
From Benzinga
From Benzinga
Do Analysts See A Path Forward For Ophthotech's Fovista?
March 24, 2017
From Benzinga
Stay Of Court Injunction A Mild Positive For Regeneron
February 09, 2017
From Benzinga
Regeneron Eyes A Comeback In 2017
December 27, 2016
From Benzinga
One Way To Look At The Ophthotech-Regeneron Pair Trade
December 12, 2016
From Benzinga
Imprimis CEO Talks Phenomenal Quarter: 'Shocking' Statistics, Simplification And A Trifecta For Success
December 01, 2016
Tickers
IMMY
From Benzinga
Hard To See If Regeneron's Eylea Combo Study Failure Reads Through To Ophthotech's Fovista
October 03, 2016
From Benzinga
From Stocks to Watch
Regeneron Is 'One Of The Stronger Growers In Biotech'
June 29, 2016
From Benzinga
Regeneron’s 3Q EPS Beat Can’t Lift the Stock; Shares Down 4.5%
November 04, 2015
From Stocks to Watch
Why Avalanche Biotechnologies Is Coming Off A Big Day
June 11, 2015
From Benzinga
From Benzinga
Top Trending Tickers On StockTwits For February 11
February 11, 2014
From Benzinga
Regeneron Shares Jump As Eye Drug Meets New Study Goal
June 06, 2013
From Stocks to Watch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.